Regis Technologies, Inc.
Regis Technologies is a premier US-based API CDMO and chromatography products manufacturer. They leverage their expertise in organic synthesis and chromatography separations to offer customized solutions for small molecule development, manufacturing, and separation needs. The company aims to be a trusted partner in navigating the complex path of molecule discovery to delivery, with precision and expertise.
Industries
Nr. of Employees
medium (51-250)
Regis Technologies, Inc.
8210 Austin Ave, Morton Grove, IL 60053
Products
Chromatography columns (chiral and achiral)
Packaged analytical and preparative columns for chiral and achiral separations, available in multiple stationary phases and particle sizes.
Specialty chromatography reagents
Reagents for chromatography workflows including ion-pairing reagents and derivatization reagents.
Imaging reagents (coelenterazine, luciferin)
Small-molecule reagents used in bioluminescent assays and imaging workflows.
Chromatography columns (chiral and achiral)
Packaged analytical and preparative columns for chiral and achiral separations, available in multiple stationary phases and particle sizes.
Specialty chromatography reagents
Reagents for chromatography workflows including ion-pairing reagents and derivatization reagents.
Imaging reagents (coelenterazine, luciferin)
Small-molecule reagents used in bioluminescent assays and imaging workflows.
Services
End-to-end contract services including process development, scale-up, and GMP API manufacture for clinical and commercial supply.
Development and optimization of HPLC and SFC methods, including free chiral screening services to identify suitable separations.
Process development, route optimization, and scale-up from lab to manufacturing to improve yields, impurity profiles, and manufacturability.
Investigation of solid forms, polymorph screening, and stability testing to inform formulation and regulatory strategies.
Specialized containment and procedures for the manufacture of high-potency active pharmaceutical ingredients.
Identification and characterization of impurities using analytical techniques to support process development and regulatory filings.
End-to-end contract services including process development, scale-up, and GMP API manufacture for clinical and commercial supply.
Development and optimization of HPLC and SFC methods, including free chiral screening services to identify suitable separations.
Process development, route optimization, and scale-up from lab to manufacturing to improve yields, impurity profiles, and manufacturability.
Investigation of solid forms, polymorph screening, and stability testing to inform formulation and regulatory strategies.
Specialized containment and procedures for the manufacture of high-potency active pharmaceutical ingredients.
Identification and characterization of impurities using analytical techniques to support process development and regulatory filings.
Expertise Areas
- Custom API development and CDMO services
- cGMP manufacturing for small molecules
- Analytical method development (HPLC/SFC)
- Chiral separations and chiral screening
Key Technologies
- High-performance liquid chromatography (HPLC)
- Supercritical fluid chromatography (SFC)
- Chiral stationary phases
- Reversed-phase chromatography
News & Updates
Discussion on using columns packed with sub-2 µm fully porous particles for faster and better resolved HPLC separations.
Deep dive into ICH Q14, its role, main elements of analytical procedures, exceptions, and challenges.
Exploration of using sub-2 µm particles for high-efficiency HPLC separations.
Series of case studies in process development.
Discussion on using columns packed with sub-2 µm fully porous particles for faster and better resolved HPLC separations.
Deep dive into ICH Q14, its role, main elements of analytical procedures, exceptions, and challenges.
Exploration of using sub-2 µm particles for high-efficiency HPLC separations.
Series of case studies in process development.